Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Announcement under Regulation 30 (LODR)-Change in Management

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE ·

This is in reply to the query received from BSE dated 18th August 2025 pertaining to resignation of Mr. Manoj Lodha as Chief Financial Officer of the Company w.e.f. 5th August 2025. Resignation Letter received from Mr. Manoj Lodha submitted herewith.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases